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Chemotherapy has been used as a treatment of cancer during the past 60 years. However, 
chemotherapeutic drugs are well known for undesirable side effects due to unspecificity of the 
drugs and genetic variation between patients. One approach to eliminate unspecificity is 
targeted chemotherapy [1] using prodrugs, which are selectively activated in tumor tissue 
without affecting healthy tissues. Activation of many prodrugs is achieved through 
intracellular reduction by cytosolic redox enzymes (bioreductive activation), the most 
important of which is DT-diaphorase. In many type of cancer cells, DT-diaphorase is 
naturally overexpressed, whereas it is not the case in healthy tissues [2]. There are, however, 
cancer cells that do not possess a significant DT-diaphorase activity. Intensive research is 
ongoing to identify synthetic or naturally occurring chemical species that can selectively 
induce DT-diaphorase activity in cancer cells to widen the applicability of chemotherapeutic 
drugs relying on bioreduction [3]. Traditional screening assays based on enzyme activity 
determination in cell lysates are very labour-intensive and time consuming. 
Here, we present optimization of a mediated amperometric assay for monitoring induction of 
DT-diaphorase activity in living cancer cells as the first demonstration of the technique on 
living human cells. Detection is conducted based on the application of the double mediator 
system menadione/ferricyanide (Fig. 1). In our previous studies, these mediators have been 
applied successfully for screening of genetic modifications of S. cerevisiae cells in relation to 
cellular redox activity [4,5]. Menadione, a lipophilic quinone capable of entering the 
intracellular environment, is reduced by cytosolic redox enzymes, e.g., DT-diaphorase. Upon 
diffusing back to the extracellular environment, the reduced form of menadione delivers the 
electrons to ferricyanide, which is reoxidized at an electrode. The recorded current is an 
indication of changes in cellular reducing capacity. The project aims at assay automation 
using a modular microfluidic cell culture device analogously with our previous studies on S. 
cerevisiae [6,7].       
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Figure 1. The effect of menadione concentration and 
assay time on cellular reducing capacity in HeLa cells  
